Overview


According to FutureWise analysis the market for Hematology Testing is expected to register a CAGR of 5.42% from 2023-2031.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hematology Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hematology Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott Laboratories
  • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation (U.S.)
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Horiba, Ltd.
  • Mindray Medical International Limited
  • Nihon Kohden Corporation
  • Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
  • Siemens Healthcare (a division of Siemens AG)
  • Sysmex Corporation
  • AGAPPE DIAGNOSTICS
  • B E BIO-TECHNOLOGY
  • Balio Diagnostics
  • CLINDIAG SYSTEMS
  • Convergent Technologies
  • CPC Diagnostics
  • CPM Scientifica
  • DIAGON

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Products and Services

  • Hematology Products
    • Hematology Instruments
    • Hematology Analyzers
      • Hematology Analyzers, by Type of Automation
        • Fully Automated Hematology Analyzers
        • 5-part and 6-part Differential Hematology Analyzers
        • 3-part Differential Hematology Analyzers
        • Semi-automated Hematology Analyzers
      • Hematology Analyzers, by Complexity
        • Highly Complex Clinical Laboratory Analyzers
        • Hematology Analyzers for Point-of-Care Testing
      • Hematology Analyzers, by Price Range
        • High-end Hematology Analyzers
        • Low-range and Mid-range Hematology Analyzers
        • Slide Stainers/Markers
    • Hematology Consumables
      • Hematology Reagents
      • Hematology Stains
      • Controls and Calibrators
      • Others
  • Hematology Services
    • Simple Dripping
    • Electrostatic Dripping
    • Coaxial Airflow
    • Liquid-jet Break Up
    • Vibrating-jet Technique
    • Jet cutting Technique
    • Rotating Disk Atomization

By Type of Tests

  • Complete Blood Count Analysis
    • Hemoglobin Concentration
    • Hematocrit Determination
    • Red Blood Cell Count
    • Red Cell Indices
    • Red Cell Size Histograms
    • Other Tests
  • White Blood Cell Analysis
  • Reticulocytes
  • Hemoglobin Test
  • Platelet Function Tests
  • Erythrocyte Sedimentation Rate/CRP
  • Red Cell Analysis
  • Hemocysteine Test
  • Neutrophil Function Tests
  • Bone Marrow Analysis
  • Red Cell Deformability
  • 2, 3-bisphosphoglycerate (2, 3-DPG) Test
  • Other Tests

By End User

  • Clinical Testing Laboratories
  • Stand-alone Hospitals
  • Research Institutions
    • Public and Private Research Centers
    • Academic Institutions
  • Commercial Organizations

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Hematology Testing Market By Products and Services, By Type of Tests, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Hematology Testing Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hematology Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.  Hematology Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Hematology Testing Market, By Products and Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hematology Products
         1.1. Hematology Instruments
         1.2. Hematology Analyzers
          1.2.1. Hematology Analyzers, by Type of Automation
           1.2.1.1. Fully Automated Hematology Analyzers
           1.2.1.2. 5-part and 6-part Differential Hematology Analyzers
           1.2.1.3. 3-part Differential Hematology Analyzers
           1.2.1.4. Semi-automated Hematology Analyzers
          1.2.2. Hematology Analyzers, by Complexity
           1.2.2.1. Highly Complex Clinical Laboratory Analyzers
           1.2.2.2. Hematology Analyzers for Point-of-Care Testing
          1.2.3. Hematology Analyzers, by Price Range
           1.2.3.1. High-end Hematology Analyzers
           1.2.3.2. Low-range and Mid-range Hematology Analyzers
           1.2.3.3. Slide Stainers/Markers
         1.3. Hematology Consumables
          1.3.1. Hematology Reagents
          1.3.2. Hematology Stains
          1.3.3. Controls and Calibrators
          1.3.4. Others
        2. Hematology Services
         2.1. Simple Dripping
         2.2. Electrostatic Dripping
         2.3. Coaxial Airflow
         2.4. Liquid-jet Break Up
         2.5. Vibrating-jet Technique
         2.6. Jet cutting Technique
         2.7. Rotating Disk Atomization

  • 8.  Hematology Testing Market, By Type of Tests Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Complete Blood Count Analysis
         1.1. Hemoglobin Concentration
         1.2. Hematocrit Determination
         1.3. Red Blood Cell Count
         1.4. Red Cell Indices
         1.5. Red Cell Size Histograms
         1.6. Other Tests
        2. White Blood Cell Analysis
        3. Reticulocytes
        4. Hemoglobin Test
        5. Platelet Function Tests
        6. Erythrocyte Sedimentation Rate/CRP
        7. Red Cell Analysis
        8. Hemocysteine Test
        9. Neutrophil Function Tests
        10. Bone Marrow Analysis
        11. Red Cell Deformability
        12. 2, 3-bisphosphoglycerate (2, 3-DPG) Test
        13. Other Tests

  • 9.  Hematology Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Testing Laboratories
        2. Stand-alone Hospitals
        3. Research Institutions
         3.1. Public and Private Research Centers
         3.2. Academic Institutions
        4. Commercial Organizations

  • 10.   North America Hematology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.  Latin America Hematology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.  Europe Hematology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.  Asia Pacific Hematology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Hematology Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Beckman Coulter, Inc. (a subsidiary of Danaher Corporation (U.S.)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bio-Rad Laboratories, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boule Diagnostics AB
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Horiba, Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mindray Medical International Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nihon Kohden Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Siemens Healthcare (a division of Siemens AG)
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sysmex Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. AGAPPE DIAGNOSTICS
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. B E BIO-TECHNOLOGY
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Balio Diagnostics
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. CLINDIAG SYSTEMS
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Convergent Technologies
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. CPC Diagnostics
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. CPM Scientifica
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. DIAGON
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients